skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Understand the latest Corporate Strategies of the biggest Generics and Biosimilar players.

Get an inside view into the corporate strategies of generics’ biggest players with articles like: 
  • Teva Takes A Further Hit On Value Of Actavis
  • Slowing Biopharmaceuticals Puts A Dent In Sandoz’ Sales
  • Wait For Strategic Decisions Weighs Heavily On Mylan
  • If Amneal Goes Global Again, It Intends To Go Big
Corporate Strategies of the biggest Generics and Biosimilar players

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: